1. Home
  2. HRMY vs NSP Comparison

HRMY vs NSP Comparison

Compare HRMY & NSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Harmony Biosciences Holdings Inc.

HRMY

Harmony Biosciences Holdings Inc.

N/A

Current Price

$27.73

Market Cap

1.7B

Sector

Health Care

ML Signal

N/A

Logo Insperity Inc.

NSP

Insperity Inc.

N/A

Current Price

$20.55

Market Cap

834.9M

ML Signal

N/A

Company Overview

Basic Information
Metric
HRMY
NSP
Founded
2017
1986
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Professional Services
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
1.7B
834.9M
IPO Year
2020
1996

Fundamental Metrics

Financial Performance
Metric
HRMY
NSP
Price
$27.73
$20.55
Analyst Decision
Buy
Hold
Analyst Count
10
3
Target Price
$46.70
$47.67
AVG Volume (30 Days)
1.1M
1.2M
Earning Date
05-18-2026
05-12-2026
Dividend Yield
N/A
12.06%
EPS Growth
7.97
N/A
EPS
2.71
N/A
Revenue
$868,453,000.00
$6,812,000,000.00
Revenue This Year
$19.87
$4.27
Revenue Next Year
$12.49
$5.43
P/E Ratio
$10.62
N/A
Revenue Growth
21.51
3.51
52 Week Low
$25.52
$18.57
52 Week High
$40.87
$91.12

Technical Indicators

Market Signals
Indicator
HRMY
NSP
Relative Strength Index (RSI) 30.66 27.06
Support Level $27.66 N/A
Resistance Level $38.91 $48.32
Average True Range (ATR) 1.25 1.36
MACD 0.08 0.40
Stochastic Oscillator 54.02 39.83

Price Performance

Historical Comparison
HRMY
NSP

About HRMY Harmony Biosciences Holdings Inc.

Harmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing and commercializing therapies for patients living with rare neurological diseases who have unmet medical needs. The company has one reportable segment: rare neurological diseases. Its product WAKIX (pitolisant) is a molecule with a novel mechanism of action specifically designed to increase histamine signaling in the brain by binding to H3 receptors and is used for the treatment of cataplexy in adult patients with narcolepsy. The other drug candidates in its pipeline are Pitolisant, HBS-102 (MCHR1 antagonist), BP1.15205 (orexin-2 receptor agonist), ZYN002 (cannabidiol gel), EPX-100 (clemizole hydrochloride), and EPX-200 (lorcaserin), among others.

About NSP Insperity Inc.

Insperity Inc is a company that provides a wide range of human resources and business solutions designed to help businesses improve their performance. Small and midsize enterprises are the company's primary target customers. Majority of the company's products are offered through the company's Workforce Optimization and Workforce Synchronization solutions, which comprise various human resource functions, such as payroll and employment administration, employee benefits and compensation, government compliance, performance management, training and development services, and human capital management. The company generates all of its revenue in the United States.

Share on Social Networks: